There is substantial evidence that the JAK/STAT3 pathway has a crucial role in many fibrotic diseases, e.g., systemic sclerosis, pulmonary fibrosis, and renal fibrosis (Pedroza et al. 2016; Chakraborty et al. 2017; Liu et al. 2023). Here, STAT3 is linked to pulmonary fibrosis.